Race, ethnicity, and cognition in persons newly diagnosed with multiple sclerosis

Lilyana Amezcua1, Jessica B Smith1, Edlin G Gonzales1

  • 1From the Department of Neurology (L.A.), University of Southern California, Keck School of Medicine, Los Angeles; Department of Research & Evaluation (J.B.S., E.G.G.) and Los Angeles Medical Center, Department of Neurology (A.L.-G.), Southern California Permanente Medical Group, Pasadena; and Philadelphia College of Osteopathic Medicine (S.H.), PA.

Neurology
|March 11, 2020
PubMed
Abstract

Insights

Cognitive impairment in newly diagnosed multiple sclerosis (MS) affects all races equally. However, Black and Hispanic patients show lower Symbol Digit Modalities Test (SDMT) scores, reflecting population differences, not MS severity.

Area of Science:

  • Neurology
  • Neuroimmunology
  • Cognitive Neuroscience

Background:

  • Multiple sclerosis (MS) diagnosis is increasing, with cognitive impairment being a common symptom.
  • Understanding cognitive differences across racial/ethnic groups in early MS is crucial for accurate assessment and management.
  • Limited normative data exists for cognitive tests like the Symbol Digit Modalities Test (SDMT) in non-white populations.

Purpose of the Study:

  • To compare cognitive impairment in newly diagnosed Black and Hispanic multiple sclerosis (MS) patients versus white patients.
  • To investigate potential differences in MS disease course based on race/ethnicity.
  • To establish normative data for the oral Symbol Digit Modalities Test (SDMT) in diverse populations.

Main Methods:

  • A cohort of 1,174 adults from the MS Sunshine Study was analyzed.
  • Cognitive function was assessed using the oral Symbol Digit Modalities Test (SDMT) and verbal fluency tests.
  • Multivariable regression models were employed to identify predictors of cognitive impairment.

Main Results:

  • Lower oral SDMT scores were independently predicted by having MS/clinically isolated syndrome (CIS), lower educational attainment, and belonging to Black or Hispanic racial/ethnic groups.
  • Black and Hispanic participants, both with and without MS/CIS, exhibited lower SDMT scores compared to white participants, even after adjusting for covariates.
  • No significant interaction was found between race/ethnicity and MS/CIS status on SDMT scores, suggesting population-level differences.

Conclusions:

  • Newly diagnosed individuals with MS/CIS experience cognitive impairment compared to controls, irrespective of race/ethnicity.
  • Observed lower SDMT scores in Black and Hispanic patients reflect broader demographic disparities in cognitive function rather than differences in MS disease severity.
  • The study provides essential reference scores for the SDMT, stratified by age and education, for Black and Hispanic populations.

Related Concept Videos